Table 1.
Characterization of SPIO used in the study (average of 3 measurements). Nanoparticle concentration was either measured with NanoSight (large SPIO NW) or calculated theoretically, as described. [28] PDI, polydispersity index. All particle solutions were at 1 mg Fe/mL and had less than 0.2 EU/mL endotoxin as measured with Limulus amebocyte lysate assay.
| Particle name | Composition | Size (intensity weighted), nm | PDI | Zeta potential, mV |
|---|---|---|---|---|
| Large SPIO NW | 20kDa native dextran, multiple crystals per particle | 106 (Z-average), 126 ± 54.42 (peak) | 0.16 | −7.4 ± 6.8 |
| Small SPIO NW | 20kDa native dextran, multiple crystals per particle | 67 (Z-average), 81.36 ± 40.35 (peak) | 0.22 | −6.8 ± 8.8 |
| Ferumoxytol (Feraheme ®) | 10kDa reduced carboxymethyl dextran, 1 crystal per particle | 26 (Z-average), 26.86 ± 10.53 (peak) | 0.27 | −15.6 ± 7.4 |
| Ultrasmall SPIO (USPIO) | 10kDa reduced T-10 dextran SPIO, 1 crystal per particle | 26 (Z-average), 25.96 ± 7.64 (peak) | 0.23 | −5.0 ± 10.0 |
| Ferumoxtran-10 | 10kDa native T-10 dextran SPIO, 1-3 crystals per particle | 44 (Z-average), 51.19 ± 20.75 (peak) | 0.14 | −7.2 ± 9.5 |